Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ana González-De Arriba"'
Publikováno v:
Revista Española de Patología. 48:203-207
Resumen El hemangioma microvenular es una tumoracion vascular benigna poco frecuente, adquirida y autolimitada. Se presenta con mayor frecuencia como una placa o papula unica, eritematoviolacea en tronco o extremidades de adultos jovenes con predilec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::277ef6bbf6625500ed24e284be7db6c3
https://doi.org/10.1016/j.patol.2015.07.004
https://doi.org/10.1016/j.patol.2015.07.004
Publikováno v:
Actas Dermo-Sifiliográficas. 97:296-310
Epidermal growth factor receptor (EGFR) inhibitors are a new group of drugs used in the treatment of several malignancies. Three molecules are approved at the moment: gefitinib and erlotinib for the treatment of non-small-cell lung cancer, and cetuxi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::792e5400775a6e0a96ba6d6bea003a5a
https://doi.org/10.1016/s0001-7310(06)73407-x
https://doi.org/10.1016/s0001-7310(06)73407-x
Autor:
REBECA GOIRIZ, LUIS RÍOS-BUCETA, ANA GONZÁLEZ DE ARRIBA, MAXIMILIANO ARAGÜÉS, AMARO GARCÍA-DIEZ
Publikováno v:
Dermatologic Surgery. 35:147-149
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4312d39af0996873b5fc0208d9528302
https://doi.org/10.1097/00042728-200901000-00024
https://doi.org/10.1097/00042728-200901000-00024
Autor:
Amaro García-Díez, Maximiliano Aragüés, L. Ríos-Buceta, Rebeca Goiriz, Ana González De Arriba
Publikováno v:
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. 35(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7faba8d3793b1a858515239bf75e33e
https://pubmed.ncbi.nlm.nih.gov/19076206
https://pubmed.ncbi.nlm.nih.gov/19076206
Publikováno v:
Actas dermo-sifiliograficas. 97(5)
Epidermal growth factor receptor (EGFR) inhibitors are a new group of drugs used in the treatment of several malignancies. Three molecules are approved at the moment: gefitinib and erlotinib for the treatment of non-small-cell lung cancer, and cetuxi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::818d806a32612b8bc884b4db27c8fc78
https://pubmed.ncbi.nlm.nih.gov/16956561
https://pubmed.ncbi.nlm.nih.gov/16956561